Stock Chart

ICLR

$199.70 -2.41%
Score: 30.9 AVOID NEW MONEY
LEAPs: SELL $210
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $210
Premium: $45.43
Expiry: Nov 19, 2027
Target: $223
Score: -72

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.52x (vs SPY: 0.7x | vs QQQ: 0.6x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 11, 2026
Bull Pennant Bullish scenario quality 64/100
Setup invalidates on a close below $199.07 · pole +38% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks up 70% of the time (n=1,684). Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About ICLR - Icon Plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Key Statistics

Market Cap $15B
P/E Ratio 81.85

This ICLR stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ICLR's price movements with trendlines, gamma walls, and key support/resistance levels.